Bayer introduces OTC back pain device

Bayer introduces OTC back pain device

alevetherapy_1
German multinational pharmaeuutical company has a drug-free, device for fhe management of pain.
The device, Aleve Direct Therapy, uses transcutaneous electrical nerve stimulation (TENS), which delivers stimulating pulses to the pain site. TENS is typically used by doctors to help relieve lower back pain.
No prescription is needed for the device, which can be used for temporary relief of muscular pain in the lower back due to strain, exercise or even normal day-to-day activities.
According to Bayer’s announcement, the theory behind the therapy is that it blocks pain signals and in turn releases endorphins in the affected area.The device is operated with a wireless remote that controls the waveform technology.
The company says the device can be worn discreetly throughout the day and during some physical activities. Users go through a three-stage therapy session that can be repeated as necessary, with 30-minute breaks between sessions.
The first stage, during which high-frequency stimulation first initiates pain suppression, lasts 5 minutes. A 20-minute second stage offers low-frequency stimulation to increase the release of endorphins. The final stage lasts an additional 5 minutes and offers the same high-frequency stimulation as stage one, to maintain the feeling of pain relief.
“Aleve Direct Therapy puts controllable TENS technology in consumers’ hands without having to visit the doctor,” said Andre Schmidt, vice president of U.S. medical affairs for Bayer’s consumer health division, in the announcement.
“It provides high intensity of power and its wireless remote control makes it easy to adjust the power of intensity to fit the user’s needs.” The device is regulated as a Class II medical device and was cleared by the FDA.

About author

You might also like

Rotary budgets $96.5m to end polio

Rotary on Wednesday, August 15, 2018 announced nearly $100 million in grants to support the global effort to end polio, a vaccine-preventable disease that once paralysed hundreds of thousands of

BREAKING NEWS 0 Comments

Merck doles out 35million tablets to combat ‎Schistosomiasis in Nigeria

By Deo Akinbo Multinational pharmaceutical firm, Merck, today donated 35 million tablets of Praziquantel to help Nigerian health workers treat children infected with Schistosomiasis (or bilharzia), a parasitic disease Merck

You should lead research for vaccine production – Jonathan tells W/African pharmacologists  

Former President Goodluck Jonathan has charged members of the West African Society of Pharmacology (WASP) to spearhead research for the production of vaccines to contain epidemics that are endemic in

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply